First 5 years of measles elimination in southern Africa: 1996–2000

作者: Robin Biellik , Simon Madema , Anne Taole , Agnes Kutsulukuta , Ernestina Allies

DOI: 10.1016/S0140-6736(02)08517-3

关键词: MedicineTransmission (medicine)Clinical researchImmunizationVaccinationPopulationEl NiñoDeveloping countryPediatricsMeasles

摘要: Summary Background Measles is the leading cause of vaccine-preventable death in Africa. Regional measles elimination considered feasible using current vaccines and a series WHO-recommended strategies. We aimed to interrupt transmission measles, use case-based surveillance show effect such interruption. Methods In southern Africa from 1996, seven countries with total population approximately 70 million relatively high routine vaccination coverage implemented addition immunisation at 9 months age, these included nationwide catch-up campaigns among children aged 14 years, then follow-up every 3–4 years 9–59 months, establishment serological diagnostic confirmation. Results Nearly 24 were vaccinated, overall 91%. Reported clinical cases declined 60 000 1996 117 laboratory-confirmed 2000. deaths 166 zero No increase adverse events was noted after campaign. Conclusion A reduction mortality morbidity can be achieved very low-income countries, that split their by geographical area or age-group target population, where initial infants

参考文章(10)
Alan D. Lopez, Christopher J. L. Murray, The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. Harvard School of Public Health on behalf of the World Health Organization and the World Bank , Distributed by Harvard University Press. ,(1996)
Hiroshi Suzuki, Takatsugu Sakai, Reiko Saito, Nao Seki, Measles elimination in southern Africa The Lancet. ,vol. 360, pp. 716- 717 ,(2002) , 10.1016/S0140-6736(02)09845-8
G. De Serres, N. J. Gay, C. P. Farrington, Epidemiology of Transmissible Diseases after Elimination American Journal of Epidemiology. ,vol. 151, pp. 1039- 1048 ,(2000) , 10.1093/OXFORDJOURNALS.AJE.A010145
Bradley S Hersh, Gina Tambini, Ana Cristina Nogueira, Peter Carrasco, Ciro A de Quadros, Review of regional measles surveillance data in the Americas, 1996-99. The Lancet. ,vol. 355, pp. 1943- 1948 ,(2000) , 10.1016/S0140-6736(00)02325-4
Amra Uzicanin, Rudi Eggers, Elize Webb, Bernice Harris, Dave Durrheim, Gboyega Ogunbanjo, Veronica Isaacs, Anthony Hawkridge, Robin Biellik, Peter Strebel, Impact of the 1996–1997 supplementary measles vaccination campaigns in South Africa International Journal of Epidemiology. ,vol. 31, pp. 968- 976 ,(2002) , 10.1093/IJE/31.5.968
R. F. Helfand, J. L. Heath, L. J. Anderson, E. F. Maes, D. Guris, W. J. Bellini, Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. The Journal of Infectious Diseases. ,vol. 175, pp. 195- 199 ,(1997) , 10.1093/INFDIS/175.1.195
R. M. Anderson, H. R. Babad, D. J. Nokes, N. J. Gay, E. Miller, P. Morgan-Capner, Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options. Epidemiology and Infection. ,vol. 114, pp. 319- 344 ,(1995) , 10.1017/S0950268800057976
Ciro A. de Quadros, Measles Elimination in the Americas JAMA. ,vol. 275, pp. 224- 229 ,(1996) , 10.1001/JAMA.1996.03530270064033